Clinical Trial Update: Propaten Randomized Investigation on Cost-benefit and Efficacy [NA]

View source ↗

Summary

A randomized trial evaluating cost-benefit and efficacy in end-stage renal disease was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: End-stage Renal Disease | NA | Status: TERMINATED | Results posted: 2019-02-27